Posted on April 23rd, 2014
Medical experts in the U.S. are looking forward to utilizing a newly developed blood test that will identify whether a patient is suffering from a heart attack.
Experts in Sweden recently discovered a simple procedure that combines blood test results with electrocardiogram results to evaluate whether a heart attack is occurring. The test reportedly has a high rate of accuracy.
Stockholm doctor, Nadia Bandstein believes that this new test will prevent at least 25% of heart attack deaths. Though the new blood test procedure showed impressive results in Sweden, heart specialists in the U.S. are still curious to see other results.
The popular contraceptives, Yaz, Yasmin, and Ocella have been linked to many incidences of heart attacks and other potentially fatal medical events. If you have suffered adverse effects from your medication, the attorneys at Williams Kherkher may be able to help you pursue compensation. Call our offices at 800-761-3187 to discuss your legal options.
Posted on April 23rd, 2014
A submucous cleft palate is characterized by a split that occurs in the soft palate muscle. This kind of cleft palate can be identified by the following:
- The child may have abnormal nasal speech.
- The child has problem in properly ingesting food.
- Repeating disease in the middle ear.
- The child’s uvula is split.
Various tests are conducted by experts to figure out if a child has a submucous cleft palate. These tests can include x-rays.
When taken by a pregnant woman, the epilepsy medication, Topamax has been shown to cause birth defects in infants, which can include cleft palates as well as other malformations. If your child has suffered because of this medication, the attorneys of Williams Kherkher may be able to help you pursue compensation. Call our offices today at 800-220-9341 to discuss your options with a member of our team.
Posted on April 22nd, 2014
John Eddie Williams Jr., Managing Partner at Williams Kherkher, was recently named to the 2014 Texas Super Lawyers list. This honor is given to attorneys who exhibit excellence in practice and is determined by a rigorous selection process that includes peer review. The final list of Texas Super Lawyers that is published represents fewer than 5% of attorneys in the state. This year’s Texas Super Lawyers List will be published in Texas Super Lawyers Magazine and in Texas Monthly.
Posted on April 17th, 2014
On Tuesday, April 8 Senators Jeff Sessions and Ben Cardin passed a resolution naming April 2014 Congenital Diaphragmatic Hernia Month. The Senate, for the second time, adopted the resolution unanimously.
According to Sessions, whose grandson is a CDH survivor, the condition affects more than 1,000 infants in the United States annually. Congenital diaphragmatic hernias occur when the diaphragm fails to fully develop, which allows abdominal ordans to push into the chest cavity and hinder lung development. Since 2000, 700,000 babies worldwide have fallen victim to this condition.
The resolution was passed with the hope that increased awareness of the condition will improve treatment techniques and, ultimately, find a cure for the disease.
Should you experience negative side effects while using an AlloDerm hernia patch, you may have the right to press charges and pursue financial compensation for your medical expenses. The attorneys of Williams Kherkher have successfully represented many victims of dangerous pharmaceuticals. Call our offices today at 800-220-9341.
Posted on April 17th, 2014
The Renal Physicians Association (RPA) has introduced a new iPad application to help nephrologists make decisions when it comes to pain management techniques for acute kidney injury, end-stage renal disease, and chronic kidney disease patients.
RPA Board Member Adam Weinstein, MD, and leader of the app development team said the Shared Decision Making (SDM) Toolkit app is a mobile version of the RPA’s Clinical Practice Guideline on Shared Decision Making in the Appropriate Initiation of and Withdrawal from Dialysis, 2nd Edition.
The app helps physicians advise their patients if they should start, continue, or terminate dialysis treatments. The app provides symptom assessment and aids in real-time decision-making.
Innovations such as the SDM Toolkit app provide kidney damage patients with access to improved care. If your kidney condition has worsened from using the kidney dialysate, GranuFlo, you could be eligible to pursue compensation from the manufacturer. The attorneys at Williams Kherkher assist people who seek compensation because of dangerous medical products. Call our offices today at 800-220-9341.
Posted on April 14th, 2014
A recent study found that men who have high levels of oxidative stress are at a higher risk of sustaining brain damage if they undergo testosterone therapy.
According to the study, which will be published in the Journal of Alzheimer’s Disease April edition and was conducted by researchers at the University of North Texas Health Science Center, some Caucasian men may be negatively affected by testosterone supplements unlike Mexican-American men. The group found that Caucasian men are more likely to have high oxidative stress.
The researchers said the oxidative stress level in men indicates if testosterone can be beneficial or harmful for them. The study suggests that men who want to undergo testosterone therapy should have their blood tested by doctors to know if the supplement will benefit them.
Unfortunately, there are many other studies that have linked testosterone therapy with an increased risk of heart attack or stroke. If you have been the victim of low-T supplements, our lawyers at Williams Kherkher may be able to fight for you to get the financial compensation you need. Discuss your situation with us today by calling [phone-number].
Posted on April 10th, 2014
Hyperglycemia occurs when the body fails to absorb enough sugar from the blood, which results to a higher-than-normal blood glucose level. Although people with diabetes are at higher risk of developing this health complication, hyperglycemia may also affect individuals who are not suffering from diabetes.
There are many factors that can contribute towards the development of hyperglycemia. Some of them include:
- Lack of physical activity
- Underlying medical conditions (diabetes, infection)
- Injury, or recovery from a surgery
- Anxiety, emotional stress
- Certain medications, such as anti-psychotic drug Risperdal
In 2004, the U.S. Food and Drug Administration warned patients and prescribers about Risperdal’s danger of causing hyperglycemia. At Williams Kherkher, our legal team provides competent legal guidance and advice to anyone who plans to seek compensation from the manufacturer of this drug. Call us at (800) 220-9341 to find out more about your options and how we may be able to help you file a lawsuit.
Posted on April 10th, 2014
While the fetus develops inside the mother’s womb, the pulmonary artery connects directly to the aorta for blood circulation and oxygen delivery. This normal connection is called ductus arteriosus, which closes hours or days upon birth. However, there are instances when ductus arteriosus fails to close within the specified amount of time, leading to a congenital heart defect called patent ductus arteriosus (PDA).
Babies with this congenital heart malformation may experience one or more of these PDA symptoms:
- Difficulty eating
- Stunted or poor growth
- Bluish-colored skin
- Too much sweating during activities, such as feeding
- Trouble breathing
- Fast heart rate
Zoloft, an anti-depressant that affects the absorption of folic acid, which is essential for the prevention of birth defects, is known to increase the risk of patent ductus arteriosus among babies exposed to it while in their mother’s womb. If your baby has been a victim of this dangerous drug, evaluate your legal options by speaking with a lawyer from Williams Kherkher. You may reach us anytime at (800) 220-9341.
Posted on April 8th, 2014
Today a federal jury in Lafayette, Louisiana ordered Takeda Pharmaceuticals Co Ltd to pay $6 billion for concealing the cancer risks of the Type 2 diabetes drug, Actos.
In addition to ordering Takeda to pay punitive damages, the jury ruled that Eli Lilly and Co also pay $3 billion in punitive damages. Eli Lilly, a co-defendant throughout the trial, helped Takeda promote Actos. Actos has been related to numerous cases of bladder cancer.
Throughout the trial, the prosecution alleged that both Takeda and Eli Lilly knowingly failed to inform diabetes patients of the cancer risks associated with Actos. After the verdict was presented, legal representatives from both pharmaceutical companies stated that they intend to challenge the outcome.
Sadly, the condition of many Type-2 diabetes patients has worsened by using Actos. If your health has been effected negatively by Actos, a lawyer from Williams Kherkher may be able to help you collect compensation from the manufacturer. Call (800) 220-9341 to speak with a member of our legal team today.
Posted on April 7th, 2014
According to the United States Drug Watchdog, DePuy Pinnacle hip implants, which are all-metal implants have been recalled for causing tissue inflammation on joint linings and hip failure.
In May 2013, Science Daily presented a study that showed how important an MRI scan can be for people who are using all-metal hip implants even if they are not experiencing any form of physical pain or discomfort regarding their hip replacement. The scans have the ability to identify tissue damage even before the symptoms of this damage arise.
Hip replacement surgery is intended to bring relief to patients that have suffered from hip problems. If the hip implant fails or injures the recipient, they could be eligible to pursue compensation from the manufacturer. The DePuy hip implant has been linked to numerous injuries. The attorneys at Williams Kherkher are experienced in advocating for victims of the DePuy hip implant. Call our offices today at 800-220-9341.